Literature DB >> 29292604

OPTN/SRTR 2016 Annual Data Report: Heart.

M Colvin1,2, J M Smith1,3, N Hadley1, M A Skeans1, R Carrico4,5, K Uccellini4,5, R Lehman4,5, A Robinson4,5, A K Israni1,6,7, J J Snyder1,6, B L Kasiske1,7.   

Abstract

In 2016, 3209 heart transplants were performed in the United States. New, active listings increased 57% since 2005. The number of adult heart transplant survivors continued to increase, and in 2016, 30,622 recipients were living with heart transplants. Patient mortality following transplant has declined. The number of pediatric candidates and transplants performed also increased. New listings for pediatric heart transplants increased from 454 in 2005 to 624 in 2016. The number of pediatric heart transplants performed each year increased from 319 in 2005 to 445 in 2016. Among pediatric patients who underwent transplant in 2015, death occurred in 5.9% at 6 months and 7.2% at 1 year. .

Entities:  

Keywords:  End-stage heart failure; heart transplant; transplant outcomes; ventricular assist device

Mesh:

Year:  2018        PMID: 29292604     DOI: 10.1111/ajt.14561

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Mitochondrial transplantation prolongs cold ischemia time in murine heart transplantation.

Authors:  Kamila Moskowitzova; Borami Shin; Kaifeng Liu; Giovanna Ramirez-Barbieri; Alvise Guariento; David Blitzer; Jerusha K Thedsanamoorthy; Rouan Yao; Erin R Snay; James A H Inkster; Arzoo Orfany; David Zurakowski; Douglas B Cowan; Alan B Packard; Gary A Visner; Pedro J Del Nido; James D McCully
Journal:  J Heart Lung Transplant       Date:  2018-09-28       Impact factor: 10.247

2.  Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.

Authors:  William F Parker; Kevin Chung; Allen S Anderson; Mark Siegler; Elbert S Huang; Matthew M Churpek
Journal:  J Am Coll Cardiol       Date:  2020-06-16       Impact factor: 24.094

Review 3.  Time Is a Precious Commodity: 2018 OPTN Policy Change and the Potential to Lower Heart Transplant Waitlist Time in the Sickest Patients.

Authors:  Jamael Hoosain; Shelley Hankins
Journal:  Curr Cardiol Rep       Date:  2019-06-20       Impact factor: 2.931

4.  Sex differences in eligibility for advanced heart failure therapies.

Authors:  Rebecca S Steinberg; Aditi Nayak; Celena O'Connell; Sharon Burford; Ann Pekarek; Neile Chesnut; Robert T Cole; Divya Gupta; S Raja Laskar; Kunal Bhatt; Michael Burke; Tamer Attia; Andrew Smith; J David Vega; Alanna A Morris
Journal:  Clin Transplant       Date:  2020-03-16       Impact factor: 2.863

Review 5.  Updates on Heart Transplantation.

Authors:  Kevin S Shah; Michelle M Kittleson; Jon A Kobashigawa
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 6.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

Review 7.  Implementation of Heart Transplantation Program to Advanced Heart Failure Patients in Brazil.

Authors:  Fabiana G Marcondes-Braga; Marcely Gimenes Bonatto; Caio Ribeiro Alves Andrade; Fernando Bacal
Journal:  Curr Heart Fail Rep       Date:  2019-02

Review 8.  Donor considerations in pediatric heart transplantation.

Authors:  Nikki Singh; Muhammad Aanish Raees; Farhan Zafar
Journal:  Transl Pediatr       Date:  2019-10

9.  Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.

Authors:  Anuradha Lala; John C Rowland; Bart S Ferket; Annetine C Gelijns; Emilia Bagiella; Sean P Pinney; Alan J Moskowitz; Marissa A Miller; Francis D Pagani; Donna M Mancini
Journal:  JAMA Cardiol       Date:  2020-06-01       Impact factor: 14.676

10.  Association of Transplant Center With Survival Benefit Among Adults Undergoing Heart Transplant in the United States.

Authors:  William F Parker; Allen S Anderson; Robert D Gibbons; Edward R Garrity; Lainie F Ross; Elbert S Huang; Matthew M Churpek
Journal:  JAMA       Date:  2019-11-12       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.